Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.25 AUD | +3.22% | -0.16% | -22.91% |
Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.91% | 1.55B | |
+25.83% | 661B | |
+26.79% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.04% | 231B | |
+4.97% | 200B | |
-9.37% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- FDA Approves Phase 2 Clinical Trial for Neuren Pharmaceuticals' Prader-Willi Syndrome Drug